Registrant : Organisation or self-employed individual
| Name/company name: |
Eli Lilly and Company |
| Acronym: |
Lilly
|
| Legal status: |
Corporation
|
| Website address: |
http://www.lilly.com
|
Sections
| Section: |
II - In-house lobbyists and trade/professional associations |
| and more precisely: |
Companies & groups |
Person with legal responsibility
| Surname, Name: |
Mr
John Lechleiter
|
| Position: |
Chairman and CEO |
Permanent person in charge of EU relations
| Surname, Name: |
Mr
Stuart Hurst
|
| Position: |
Senior Director European Government Affairs and Advocacy |
Contact details:
| Contact details of organisation's head office: |
1 Lilly Corporate Centre
Indianapolis 46285
UNITED STATES
|
| Telephone number: |
(+1) 3172762000 |
| Fax number: |
(+) |
| Other contact information: |
Lilly EU Public Affairs
c/o Eli Lilly Benelux SA
Rue du Marquis 1
BE-1000 Brussels
+32 2 548 86 86
|
Goals / remit
| Goals / remit of the organisation: |
Eli Lilly and Company is a leading innovative biopharmaceutical company committed to developing best-in-class medicines that help people live longer, healthier and more active lives. Headquartered in the US, Lilly has a major presence in Europe, with approximately 20% of a total 38.000 employees based here. In 2011 global revenue was approx. $24 billion, of which over 21% were invested in R&D (source: Full Year 2011 results http://newsroom.lilly.com/releasedetail.cfm?ReleaseID=643979)
ELANCO is the animal health branch of Eli Lilly and Company. ELANCO is a global, innovation-driven department of Eli Lilly and Company and develops and markets products to improve animal health and protein production in more than 75 countries. Elanco is committed to protein production, companion animal health and food safety and its products help the food industry produce an abundant supply of safe, nutritious and affordable food. Additionally, they enhance animal health, wellness and the human-pet bond.
Both sectors are part of Eli Lilly and Company as a single legal entity.
|
|
The organisation's fields of interests are:
|
|
Number of persons engaged in activities falling under the scope of the Transparency Register
| Number of persons: |
9
|
|
Complementary information:
|
Note: some are full-time engaged in the Brussels office and will spend approx 35% of time with EU affairs, whereas others may only spend a fraction of their time (5-10%).
|
Persons accredited for access to European Parliament premises
| First name
|
Surname
|
Start Date |
End Date |
|
Alexander Josef
|
ANTON
|
04/04/13
|
22/03/14
|
|
Hugh Thomas
|
PULLEN
|
26/03/13
|
22/03/14
|
Activities
Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:
|
EU 2020,Innovation Union,Pharmaceuticals, healthcare, innovation and research, animal health, animal welfare, animal performance, intellectual property, business competitiveness, trade, common agricultural policy, climate action, food safety
|
Fields of interest for e-mail alerts on consultations and roadmaps;
| Fields declared by the organisation: |
- Agriculture and Rural Development
- Competition
- Consumer Affairs
- Customs
- Development
- Economic and Financial Affairs
- Employment and Social Affairs
- Enterprise
- Environment
- External Relations
- General and Institutional Affairs
- Information Society
- Internal Market
- Justice and Fundamental Rights
- Public Health
- Research and Technology
- Taxation
- Trade
|
Networking
Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.
|
Eli Lilly and Company is a member of the following associations:
EFPIA, EuropaBio, AmChamEU, the British Chamber of Commerce to the EU, IFAH-Europe, FEFAC.
note: All of those associations are registered within the EU transparency register.
|
Financial data
| Financial year: |
01/2011
-
11/2011
|
|
Estimated costs to the organisation directly related to representing interests to EU institutions in that year:
|
450000
€ - 500000
€
|
|
Amount and source of funding received from the EU institutions in financial year n-1 of registration
|
|
Procurement:
|
0 €
|
|
Grants:
|
0 €
|
Other (financial) information provided by the organisation:
|
This estimate is calculated according to pro-rate salary costs of Eli Lilly and Company staff involved in interest representation towards the European institutions, based on the proportion of employee time devoted to these activities. According to the Transparency Register Compliance guidelines on financial information, this estimate includes fees paid for outsourced activities (i.e consultancy contract fees). The estimate excludes membership fees to the various Trade Associations, as those organizations have registered themselves. This list is included in the “networks” session of this form.
|
|
